Breast cancer in South East Asia: Comparison of presentation and outcome between a middle income and a high income country

World Journal of Surgery

Volumn 36, Issue 12, 2012, Pages 2838-2846

  Saxena, Nakul ^a   Hartman, Mikael ^a,b   Bhoo Pathy, Nirmala ^c,d   Lim, Jennifer N W ^e   Aw, Tar Ching ^f   Iau, Philip ^b   Taib, Nur Aishah ^g   Lee, Soo Chin ^h   Yip, Cheng Har ^g   Verkooijen, Helena M ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^g UNIVERSITY OF MALAYA   (Malaysia)

^h NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EARLY DIAGNOSIS; EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE DISPARITY; HEALTH DISPARITY; HUMAN; MALAYSIA; MASTECTOMY; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; REGISTER; SINGAPORE; STATISTICAL MODEL; STATISTICS; SURVIVAL; TREATMENT OUTCOME; UTILIZATION REVIEW;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; LOGISTIC MODELS; MALAYSIA; MASTECTOMY; MIDDLE AGED; PROGNOSIS; REGISTRIES; SINGAPORE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84874003426     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1746-2     Document Type: Article

References (52)

1. Yip CH (2009) Breast cancer in Asia. Methods Mol Biol 471: 51-64
2. Yip CH, Cazap E, Anderson BO et al (2011) Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative. Breast 20(Suppl 2):S12-S19
3. Ravdin PM, Cronin KA, Howlader N et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670-1674
4. Wang PP, CaoY(1996) Incidence trends of female breast cancer in Saskatchewan, 1932-1990. Breast Cancer Res Treat 37:197-207
5. Fontenoy AM, Leux C, Delacour-Billon S et al (2010) Recent trends in breast cancer incidence rates in the Loire-Atlantique, France: a decline since 2003. Cancer Epidemiol 34:238-243
6. Takiar R, Srivastav A (2008) Time trend in breast and cervix cancer of women in India-(1990-2003). Asian Pac J Cancer Prev 9:777-780
7. Medina VM, Laudico A, Mirasol-Lumague MR et al (2010) Cumulative incidence trends of selected cancer sites in a Philippine population from 1983 to 2002: a joinpoint analysis. Br J Cancer 102:1411-1414
8. Sim X, Ali RA, Wedren S et al (2006) Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002. BMC Cancer 6:261
9. Seow A, Koh WP, Chia KS et al. (2004) Trends In Cancer Incidence In Singapore 1968-2002 Singapore Cancer Registry, Singapore
10. Hirabayashi Y, Zhang M (2009) Comparison of time trends in breast cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX. Jpn J Clin Oncol 39:411-412
11. Ministry of Health http://www.moh.gov.sg/mohcorp/statistics.aspx?id=5524. Accessed July 2011
12. World Bank. Country Classification http://data.worldbank.org/country/ singapore. Accessed July 2011
13. Department of Statistics Singapore http://www.singstat.gov.sg/stats/ latestdata.html. Accessed July 2011
14. Lim M-K (2009) Health Care Reforms in Singapore: Six Countries, Six Reform Models: The Health Care Reform, World Scientific Publishing Co. Pte. Ltd
15. Malaysia. US Department of State (2010) http://www.state.gov/r/pa/ei/bgn/ 2777.htm
16. World Bank. Country classification. http://data.worldbank.org/country/ malaysia. Accessed July 2011
17. Barraclough S (1997) The growth of corporate private hospitals in Malaysia: policy contradictions in health system pluralism. Int J Health Serv 27:643-659
18. Francis T (2009) Health care in Malaysia: the dynamics of provision, financing and access. In: Barraclough S (ed) Heng Leng Chee SB. Routledge, London
19. Newman LA, Mason J, Cote D et al (2002) African-American ethnicity, socioeconomic status, and breast cancer survival. Cancer 94:2844-2854
20. Kogevinas M Pearce N, Susser M et al., eds. (1997) Social Inequalities and Cancer. IARC Scientific Publications no. 138, Lyon, France
21. Webster TF, Hoffman K, Weinberg J et al (2008) Communityand individual-level socioeconomic status and breast cancer risk: multilevel modeling on Cape Cod, Massachusetts. Environ Health Perspect 116:1125-1129
22. Barbone F, Filiberti R, Franceschi S et al (1996) Socioeconomic status, migration and the risk of breast cancer in Italy. Int J Epidemiol 25:479-487
23. Ferlay J, Shin H-R, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917
24. Singapore Cancer Registry Report (2010) Trends in cancer incidence in Singapore 1968-2007. http://www.nrdo.gov.sg/
25. Yip CH, Taib NA, Mohamed I (2006) Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev 7:369-374
26. Bouchardy C, Verkooijen HM, Fioretta G (2006) Social class is an important and independent prognostic factor of breast cancer mortality. Int J Cancer 119:1145-1151
27. Pathy NB, Yip CH, Taib NA et al (2011) Breast cancer in a multiethnic Asian setting: results from the Singapore-Malaysia Hospital-based breast cancer registry. Breast 20(Suppl 2):S75-S80
28. Lim SE, Back M, Quek E et al (2007) Clinical observations from a breast cancer registry in Asian women. World J Surg 31:1387-1392
29. Sant M, Allemani C, Capocaccia R et al (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106:416-422
30. Gondos A, Bray F, Brewster DH et al (2008) Recent trends in cancer survival across Europe between 2000 and 2004: a modelbased period analysis from 12 cancer registries. Eur J Cancer 44: 1463-1475
31. Pineda MD, White E, Kristal AR et al (2001) Asian breast cancer survival in the US: a comparison between Asian immigrants, US-born Asian Americans and Caucasians. Int J Epidemiol 30: 976-982
32. Moller H, Sandin F, Bray F et al (2010) Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer 127:2630-2638
33. Redaniel MT, Laudico A, Mirasol-Lumague MR et al (2010) Breast cancer survival in different country settings: comparisons between a Filipino resident population, Filipino-Americans and Caucasians. Breast 19:109-114
34. Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163:49-56
35. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150
36. Curado MP, Voti L, Sortino-Rachou AM (2009) Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care. Cancer Causes Control 20:751-756
37. Sankaranarayanan R, Swaminathan R, Brenner H et al (2009) Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 11:165-173
38. Dahlui M, Ramli S, Bulgiba AM (2011) Breast cancer prevention and control programs in Malaysia. Asian Pac J Cancer Prev 12: 1631-1634
39. Eley JW, Hill HA, Chen VW et al (1994) Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272: 947-954
40. Ooi SL, Martinez ME, Li CI (2011) Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 127:729-738
41. Schopper D, de Wolf C (2009) How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 45:1916-1923
42. Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476
43. Kaffashian F, Godward S, Davies T et al (2003) Socioeconomic effects on breast cancer survival: proportion attributable to stage and morphology. Br J Cancer 89:1693-1696
44. Lee-Feldstein A, Anton-Culver H, Feldstein PJ (1994) Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA 271: 1163-1168
45. Early Breast Cancer Trialists' Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687-1717
46. Chong HY, Taib NA, Rampal S et al (2011) Treatment options for locally advanced breast cancer-experience in an Asian tertiary hospital. Asian Pac J Cancer Prev 11:913-917
47. Holmes MD, Chen WY, Feskanich D et al (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293: 2479-2486
48. Taib NA, Yip CH, Low WY (2011) Recognising symptoms of breast cancer as a reason for delayed presentation in Asian Women-the psycho-socio-cultural model for breast symptom appraisal: ppportunities for intervention. Asian Pac J Cancer Prev 12:1601-1608
49. Schonberg MA, Marcantonio ER, Li D et al (2009) Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol 28:2038-2045
50. Early Breast Cancer Trialists' Collaborative Group (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 378:1707-1716
51. Nakul S, Mikael H, Zakir H et al (2011) Impact of older age on presentation, management and outcome of breast cancer in the multi-ethnic Asian population of Singapore. J Geriatric Oncol 2: 50-57
52. Krell J, James CR, Shah D et al (2011) Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcome. Clin Breast Cancer 11:153-160